You are here

Pharmaceuticals and Healthcare

The business of vital innovation

Share

The pharmaceutical and healthcare sector is one of the world’s most vital and innovative.

Against a backdrop of technological change and an increasing and aging population, we partner with our clients to help them achieve their goals, capitalise on opportunities and navigate uncertainty.

Combining deep scientific, technical and strategic knowledge we help our clients by providing the commercial nous, experience and range of services that only a large international professional services firm can offer, to anticipate and deliver innovative and value-enhancing solutions.

Recent Experience

Indivior plc

in connection with the Relationship Agreement and settlement reached with the Company’s largest shareholder, the activist investor Scopia Management

Parkinson's UK

on its acquisition of assets relating to the research, development, manufacture and marketing of glial-cell line-derived neurotrophic factor (GDNF), a potentially disease-modifying treatment for Parkinson's disease

SK Holdings

on its acquisition of Yposkesi, a French market leader in gene therapy and viral vector manufacturing

Acacia Research Corporation

on its entry into an agreement with Link Fund Solutions Limited to purchase shares in up to 19 public and private life sciences companies from the LF Equity Income Fund for up to £223.9 million.

FederFARMACO

a company representing pharmaceutical wholesalers, on regulatory affairs and intellectual property matters

Mirnagreen

 in relation to the launch and correct classification of new products based on a disruptive technology for extracting microRNA from plants, including advising on strategy to mitigate risks related to a misclassification under the contiguous categories of medicinal products, novel food and food supplements

Insights and updates

18th November 2021
‘Cyber-ransoms’ are on the rise, and with new cyber tactics and ways of working, the...
24th June 2021
The Federal Court has rejected the Australian Patent Office’s historical approach to patent term extension...
21st June 2021
As Australia moves to liberalise oversight of mobile health apps, we ask if such reforms...
26th May 2021
The Australian Consumer Law marked its tenth anniversary on 1 January 2021. Some belated presents...

Related news and deals

10 November 2021

Kewei adds corporate senior consultant Angela Zhao to China joint operation with Herbert Smith Freehills 科伟律师事务所迎来公司事务资深顾问赵秋丹 加入与史密夫斐尔联营办公室

15 October 2021

Herbert Smith Freehills advises sponsors on Abbisko’s HK$1.754 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为和誉开曼17.54亿港元IPO提供法律服务

24 August 2021

Herbert Smith Freehills advises sponsors on Acotec Scientific’s HK$1.529 billion Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人境外律师为先瑞达医疗15.29亿港元IPO提供法律服务

20 August 2021

Herbert Smith Freehills advises on Shanghai HeartCare Medical's HK$1.13 billion Hong Kong IPO 史密夫斐尔律师事务所为心玮医疗11.3亿港元IPO提供法律服务